ADMA Biologics reported FY 2024 revenue of $426.5 million, achieving significant increases in net income and adjusted EBITDA. ADMA Biologics, Inc. reported strong financial results for FY 2024, ...

Yuanbao Inc. reports Q1 2025 revenues of RMB970.1 million, up 43.8%, with net income increasing 122.1%. Yuanbao Inc., a leading online insurance distributor in China, reported strong financial results ...